Moreover, the percentages of CD69+ ILC2s were positively correlated with aggravation of liver fibrosis in patients with liver diseases, suggesting that ILC2s may contribute to the immunopathology of liver fibrosis [46]. Here, CD69 is linked to Hepatic fibrosis.